Estrogen Receptor Alpha Gene Amplification Is an Independent Predictor of Long-Term Outcome in Postmenopausal Patients with Endocrine-Responsive Early Breast Cancer.
Christian F Singernull nullFrederik HolstStefan SteurerEike C BurandtSigurd F LaxRaimund JakeszMargaretha RudasHerbert StögerRichard Greilnull nullGuido SauterMartin Filipitsnull nullRonald SimonMichael Gnantnull nullPublished in: Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Focal ESR1 amplification is an independent and powerful predictor for long-term distant recurrence-free and breast cancer-specific survival in postmenopausal women with endocrine-responsive early-stage breast cancer who received tamoxifen for 5 years.